We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Transfusion Management System Assures Patient Safety

By Labmedica staff writers
Posted on 29 Jul 2008
A point-of-care (POC) transfusion safety management system assists nurses, phlebotomists, and laboratory personnel in assuring that blood samples are drawn from correct patients and administered to suitable patients. More...


The new POC transfusion safety-management system is composed of computers, a software application, wireless handheld barcode scanners, and wireless printers. In addition to helping laboratory personnel in the accurate matching of blood samples with correct blood or blood products, it enables immediate documentation of any adverse reaction data.

A product of IntelliDOT Corp. (San Diego, CA, USA), the management system is called the IntelliDOT blood product administration (IntelliDOT BPA). The company announced that the U.S. Food and Drug Administration (FDA; Rockville, MD, USA) granted 510(k) clearance for the IntelliDOT BPA for commercial sale.

"The FDA approval for IntelliDOT blood product administration advances our corporate mission to provide innovative and easy-to-adopt, point-of-care solutions to enhance patient safety, improve nurse efficiency, and help hospitals reduce risk and liability,” said Thomas G. Klopack, president and CEO of IntelliDOT. "With this latest addition, IntelliDOT extends its ability to support improved quality of care across the full spectrum of patient needs.”

IntelliDOT BPA is an integrated module of the IntelliDOT CAREt system, the manager that connects caregivers with the information systems they need at the point-of-care. The other currently available modules in the CAREt system include: IntelliDOT bedside medication administration, IntelliDOT phlebotomy specimen collection, IntelliDOT mother-baby breast milk matching, and IntelliDOT vital signs collection.

IntelliDOT is a provider of wireless, handheld, barcode point-of- care (BPOC) solutions that connect to any healthcare information system to improve patient safety and nurse workflow. When using the IntelliDOT system, nurses can easily manage all tasks associated with medication-administration safety checks and related documentation.


Related Links:
U.S. Food and Drug Administration
IntelliDOT

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Rapid Test Reader
DIA5000
New
Candida Glabrata Test
ELIchrom Glabrata
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.